NO973198L - Aryl- og heteroarylpurinforbindelser - Google Patents

Aryl- og heteroarylpurinforbindelser

Info

Publication number
NO973198L
NO973198L NO973198A NO973198A NO973198L NO 973198 L NO973198 L NO 973198L NO 973198 A NO973198 A NO 973198A NO 973198 A NO973198 A NO 973198A NO 973198 L NO973198 L NO 973198L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
halogen
ring
substituted
Prior art date
Application number
NO973198A
Other languages
English (en)
Norwegian (no)
Other versions
NO973198D0 (no
Inventor
Franco Buzzetti
Maria Gabriella Brasca
Antonio Longo
Dario Ballinari
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9523242.7A external-priority patent/GB9523242D0/en
Priority claimed from GBGB9524131.1A external-priority patent/GB9524131D0/en
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO973198D0 publication Critical patent/NO973198D0/no
Publication of NO973198L publication Critical patent/NO973198L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO973198A 1995-11-14 1997-07-09 Aryl- og heteroarylpurinforbindelser NO973198L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9523242.7A GB9523242D0 (en) 1995-11-14 1995-11-14 Aryl and heteroaryl purine compounds
GBGB9524131.1A GB9524131D0 (en) 1995-11-24 1995-11-24 Pyrido-pyrimidine compounds as tyrosine kinase inhibitors
PCT/EP1996/004460 WO1997018212A1 (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds

Publications (2)

Publication Number Publication Date
NO973198D0 NO973198D0 (no) 1997-07-09
NO973198L true NO973198L (no) 1997-07-09

Family

ID=26308112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973198A NO973198L (no) 1995-11-14 1997-07-09 Aryl- og heteroarylpurinforbindelser

Country Status (17)

Country Link
US (1) US5965563A (es)
EP (1) EP0802914B1 (es)
JP (1) JPH10512896A (es)
CN (1) CN1168138A (es)
AR (1) AR004320A1 (es)
AT (1) ATE201873T1 (es)
AU (1) AU7292096A (es)
BR (1) BR9607089A (es)
CA (1) CA2209598C (es)
DE (1) DE69613211T2 (es)
EA (1) EA000072B1 (es)
ES (1) ES2159760T3 (es)
HU (1) HUP9801177A3 (es)
IL (1) IL121090A0 (es)
NO (1) NO973198L (es)
PL (1) PL321296A1 (es)
WO (1) WO1997018212A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
TW321649B (es) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
DE69613367T2 (de) * 1995-04-27 2002-04-18 Astrazeneca Ab, Soedertaelje Chinazolin derivate
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
WO1997030035A1 (en) 1996-02-13 1997-08-21 Zeneca Limited Quinazoline derivatives as vegf inhibitors
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
WO1997032856A1 (en) 1996-03-05 1997-09-12 Zeneca Limited 4-anilinoquinazoline derivatives
ATE213730T1 (de) 1996-04-12 2002-03-15 Warner Lambert Co Umkehrbare inhibitoren von tyrosin kinasen
HRP970371A2 (en) * 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
WO1999002162A1 (en) * 1997-07-12 1999-01-21 Cancer Research Campaign Technology Limited Cyclin dependent kinase inhibiting purine derivatives
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
TW505646B (en) 1998-06-19 2002-10-11 Pfizer Prod Inc Pyrrolo [2,3-d] pyrimidine compounds
WO2001004111A1 (en) 1999-07-09 2001-01-18 Glaxo Group Limited Anilinoquinazolines as protein tyrosine kinase inhibitors
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
UA72946C2 (uk) 1999-11-05 2005-05-16 Астразенека Аб Похідні хіназоліну як інгібітори васкулярного ендотеліального фактора росту (vegf)
PL218519B1 (pl) 1999-12-10 2014-12-31 Pfizer Prod Inc Związki pirolo [2,3-d] pirymidynowe, środek farmaceutyczny zawierający te związki oraz ich zastosowanie
SK17342002A3 (sk) 2000-06-26 2004-06-08 Pfizer Products Inc. Derivát pyrolo[2,3-d]pyrimidínu ako činidlo potlačujúce imunitu
US7301023B2 (en) 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
AU2002346729A1 (en) * 2001-12-20 2003-07-09 Bristol-Myers Squibb Company Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
EP1352910A1 (en) * 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
EP1572213A1 (en) 2002-11-26 2005-09-14 Pfizer Products Inc. Method of treatment of transplant rejection
MXPA06001758A (es) * 2003-08-15 2006-08-11 Irm Llc Anilino purinas sustituidas en la posicion 6 utiles como inhibidores de rtk.
US7626030B2 (en) 2004-01-23 2009-12-01 Amgen Inc. Compounds and methods of use
KR20070026390A (ko) * 2004-01-23 2007-03-08 암젠 인코포레이션 화합물 및 사용방법
ES2294400T3 (es) * 2004-06-29 2008-04-01 Grunenthal Gmbh Nuevos analogos de notrobenciltioinosina.
EP1827434B1 (en) * 2004-11-30 2014-01-15 Amgen Inc. Quinolines and quinazoline analogs and their use as medicaments for treating cancer
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
WO2007081517A2 (en) 2005-12-21 2007-07-19 Abbott Laboratories Anti-viral compounds
JP2009521479A (ja) * 2005-12-21 2009-06-04 アボット・ラボラトリーズ 抗ウイルス化合物
TWI399380B (zh) * 2006-12-20 2013-06-21 Abbott Lab 抗病毒化合物
ES2417009T3 (es) * 2007-10-29 2013-08-05 Amgen, Inc Derivados de benzomorfolina y métodos de uso
WO2010020905A1 (en) 2008-08-20 2010-02-25 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
DE102011111400A1 (de) * 2011-08-23 2013-02-28 Merck Patent Gmbh Bicyclische heteroaromatische Verbindungen
ES2592404T3 (es) 2012-05-21 2016-11-30 Bayer Pharma Aktiengesellschaft Benzotienopirimidinas sustituidas
TW201412740A (zh) * 2012-09-20 2014-04-01 Bayer Pharma AG 經取代之吡咯并嘧啶胺基苯并噻唑酮
ES2686909B1 (es) 2017-03-22 2019-08-16 Consejo Superior Investigacion Compuestos inhibidores de cdc-7 y su uso para el tratamiento de patologias neurologicas
FR3066761B1 (fr) * 2017-05-23 2020-10-30 Centre Nat Rech Scient Nouveaux composes inhibiteurs des canaux ioniques

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB828522A (en) * 1956-11-02 1960-02-17 Geigy Ag J R Purine derivatives and a process for the preparation thereof
US3112192A (en) * 1960-09-19 1963-11-26 Shell Oil Co Preservation of cut flowers
AU575438B2 (en) * 1984-10-26 1988-07-28 Warner-Lambert Company N6 - substituted deoxyribose analogues of adenosines
US4751292A (en) * 1985-07-02 1988-06-14 The Plant Cell Research Institute, Inc. Adamantyl purines
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
EP0457773A4 (en) * 1989-01-31 1993-03-10 Whitby Research Incorporated N?6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5034393A (en) * 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
UA41297C2 (uk) * 1991-11-25 2001-09-17 Пфайзер, Інк. Похідні індолу, фармацевтична композиція і спосіб лікування
US5670501A (en) * 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines

Also Published As

Publication number Publication date
US5965563A (en) 1999-10-12
ES2159760T3 (es) 2001-10-16
NO973198D0 (no) 1997-07-09
IL121090A0 (en) 1997-11-20
ATE201873T1 (de) 2001-06-15
AR004320A1 (es) 1998-11-04
JPH10512896A (ja) 1998-12-08
DE69613211T2 (de) 2001-11-15
CA2209598A1 (en) 1997-05-22
CA2209598C (en) 2005-06-07
DE69613211D1 (de) 2001-07-12
BR9607089A (pt) 1997-11-11
EP0802914B1 (en) 2001-06-06
EP0802914A1 (en) 1997-10-29
HUP9801177A2 (hu) 1998-09-28
MX9705010A (es) 1997-10-31
AU7292096A (en) 1997-06-05
HUP9801177A3 (en) 1998-11-30
CN1168138A (zh) 1997-12-17
PL321296A1 (en) 1997-12-08
EA000072B1 (ru) 1998-06-25
EA199700107A1 (ru) 1997-12-30
WO1997018212A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
NO973198L (no) Aryl- og heteroarylpurinforbindelser
CY1117132T1 (el) Παραγωγο θειαζολιου
LU92113I2 (fr) Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
ATE373656T1 (de) Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
KR950008512A (ko) 이미다조피리딘 유도체의 제조방법
NO20080917L (no) Nytt heterocyklidenacetamidderivat
GB1495526A (en) Chroman derivatives
DE69824332D1 (de) N-Aryl-piperidinderivate und ihre Verwendung als 5-HT1B-Rezeptorliganden
YU19890A (sh) Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje
AR017189A1 (es) Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento
EA199801013A1 (ru) Производные дистамицина, способ их получения и применение в качестве противоопухолевых и противовирусных агентов
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
EP1473295A4 (en) BICYCLIC FUSIONED PYRIMIDINE DERIVATIVES
ATE194982T1 (de) Benzoxazepin-derivate als cholinesterase- inhibitoren
PL91738B1 (es)
AR036734A1 (es) Derivados de 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxilico
IS2282B (is) Ný lyfefnasambönd með alfa2viðtakavirkni
ATE58902T1 (de) Penem-derivate.
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
YU11494A (sh) Postupak za dobijanje derivata piperazinilkamforsulfonila kao antagonista oksitocina
NO20044331L (no) Kondenserte bicykliske pyrimidinderivater
DE69319900D1 (de) N,n'-disubstituierte amidderivate
EA199800720A1 (ru) Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора
DE69626624D1 (de) Medikamente gegen trhombocytopenie
NO955071L (no) abeo-Ergolin-derivater som 5HT1A-ligander